SEC Form 4 reporting owner

Johnson David Lee

Johnson David Lee has filed 4 Form 4 transactions reported between February 4, 2026 and February 23, 2026, as Chief Operating Officer of Vera Therapeutics, Inc. and Director of Caribou Biosciences, Inc..

Name as filed: JOHNSON DAVID LEE

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$108K

1 lines

Companies

with Form 4 filings

Latest transaction

Feb 23, 2026

transaction date

Roles and reported holdings

VERAVera Therapeutics, Inc.
Feb 4, 2026 – Feb 23, 2026
Chief Operating Officer
Held directly45,727 sh as of Feb 23, 2026 · Form 4
24 months: $108K sold
CRBUCaribou Biosciences, Inc.
Feb 20, 2026
Director
No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 4 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Feb 23, 2026	VERAChief Operating Officer	Open-market saleCode S · direct	2,579	$41.98	$108K@ $41.98	45,727	Form 4
Feb 20, 2026	CRBUDirector	Grant or awardCode A · direct	45,000	—	—	45,000	Form 4
Feb 4, 2026	VERAChief Operating Officer	Grant or awardCode A · direct	40,000	—	—	40,000	Form 4
Feb 4, 2026	VERAChief Operating Officer	Grant or awardCode A · direct	20,000	—	—	48,306	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.